Travere Therapeutics Inc (TVTX)
$14.27 $0.59 (4.32%) 4:37 PM 10/05/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$1.07B -
Day's Range
$13.87 - $14.56 -
Volume
- -
52 Week Low / High
$5.12 - $15.36 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
TVTX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 9
- Strong Buy
- 3
- Buy
- 3
- Hold
- 0
- Sell
- 0
- Strong Sell
- $16.21
- Target Price
Company News
-
FDA approves expanded indication making FILSPARI available to patients with IgA nephropathy (IgAN) at risk of progression; updated label includes data showing long-term durable benefit on proteinuria and kidney function preservation that accrued over two years Conversion to full approval ...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$